1. Home
  2. Buyout

Category: Pharma and Healthcare

EQT Future to invest in fruit genetics companies SNFL, IFG to improve agricultural value proposition

EQT has used its Future Fund to makde a significant minority investment in two innovators in fruit genetics. The post EQT Future to invest in fruit genetics companies SNFL, IFG to improve agricultural value proposition

EQT invests in SNFL and IFG in second deal via Future fund

EQT has made its second investment through the EQT Future fund, taking a minority stake in two fruit genetic companies SNFL and IFG.

ArchiMed circulates teasers for Bomi auction

Private equity firm ArchiMed has launched a sale process for Italian logistics company Bomi, four sources familiar with the situation said.

SEC Proposes Additional Private Fund Disclosures

Posted by Ellen Kaye Fleishhacker, Robert Holton, and Patrick Derocher, Arnold & Porter LLP, on Friday, March 4, 2022 Editor's Note: Ellen Kaye Fleishhacker and Robert Holton are partners and Patrick Derocher is an associate

Chinese healthcare PE house CBC Group beats Fund V target to raise almost $1.6bn

Chinese healthcare private equity house CBC Group has beaten its target for its latest fund by raising close to $1.6bn. The post Chinese healthcare PE house CBC Group beats Fund V target to raise almost

Limerston exits Prism to Charme

Limerston Capital has sold UK mobility solutions provider Prism Healthcare to Charme Capital.

Gilde Equity Management explores Avinty exit advised by Arma

Gilde Equity Management has appointed Arma Partners to exit Avinty, a Netherlands-based healthcare software provider, two sources familiar with the situation said.

Montagu bolsters senior leadership team with two hires

Healthcare and tech-focused private equity firm Montagu has made two new hires to its senior leadership team in London. Louise Denning joins as CFO and Tim Cochrane as head of the full potential partners (FPP),

Blackstone names Jagannath to new global healthcare investing role, makes two more senior promotions

Global buyout giant Blackstone has made a trio of senior appointments targeting healthcare dealmaking, including for its newly-created global head of healthcare investing role. The post Blackstone names Jagannath to new global healthcare investing role,

Covid-testing component maker BioEcho gets Ampersand Capital backing

Life sciences and healthcare-focused private equity house Ampersand Capital Partners has bought into BioEcho Life Sciences, a maker of nucleic acid purification solutions for molecular diagnostics and life sciences research. The post Covid-testing component maker BioEcho

Kartesia invests into NHS main contractor Darwin Group

Pan-European focused fund house Kartesia has made a significant funding into Darwin Group. The post Kartesia invests into NHS main contractor Darwin Group first appeared on AltAssets Private Equity News.

Doxx to collect initial bids amid fierce midmarket sponsor interest

Doxx, a German digital healthcare staffing specialist, is drawing interest from a swathe of private equity players as it gears up to collect indicative this week, four sources familiar with the situation said.

Quadriga postpones LR Health & Beauty IPO

German LR Health & Beauty has postponed a planned listing on the Frankfurt Stock Exchange, three sources familiar with the matter said.

IK small cap fund invests in Sofia

IK Partners has invested in Sofia Développement Group, a French e-health company, through its IK Small Cap III fund.

IK Partners picks French e-health business Sofia as latest deal

Pan European buyout house IK Partners has agreed to tap its €1.2bn Small Cap III Fund to invest in French e-health business Sofia Développement Group. The firm joins existing shareholders Extens, Capital Croissance and Bpifrance as

Advent seeks to buy Chinese bakery chain Wagas at up to $1bn valuation – report

Global buyout major Advent International is in advanced talks to buy Chinese health-food and bakery chain Wagas, Bloomberg reported, quoting sources. The post Advent seeks to buy Chinese bakery chain Wagas at up to $1bn

AlbionVC hires Gilmartin from McKinsey

AlbionVC, a venture capital firm focused on health technology, has hired Molly Gilmartin from McKinsey, where she focused on healthcare systems and technology for two years.

UCB, Ysios lead EUR 50m Series A for SpliceBio

UCB Ventures and Ysios Capital have led a EUR 50m Series A for SpliceBio, a Spanish biotech company working on protein splicing for gene therapies.

Hildred Capital Management clears target for debut institutional fundraise, bags over $360m

Healthcare-focused private equity house Hildred Capital Management has beaten its target for its debut institutional fundraise by raising more than $360m. The post Hildred Capital Management clears target for debut institutional fundraise, bags over $360m

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.